Try

Arrowhead Pharmaceuticals Inc.

ARWRUnited States

62 filed reports · 598 financial concepts · 2 earnings calls · 2 media appearances

Filed reports

62 reports · Jun 2011 to Jun 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR466,762Jun 2011 to Jun 2026
Annual · 10-KSEC EDGAR155,332Sep 2011 to Sep 2025
Annual · 10-K/ASEC EDGAR11Sep 2024

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q310-QJun 30, 2026Aug 4, 2026440Open
FY2026 Q210-QMar 31, 2026May 7, 2026244Open
FY2026 Q110-QDec 31, 2025Feb 5, 2026243Open
FY202510-KSep 30, 2025Nov 25, 2025767Open
FY2025 Q310-QJun 30, 2025Aug 7, 2025172Open
FY2025 Q210-QMar 31, 2025May 12, 2025145Open
FY2025 Q110-QDec 31, 2024Feb 10, 2025141Open
FY202410-K/ASep 30, 2024Oct 10, 20251Open
FY202410-KSep 30, 2024Nov 26, 2024352Open
FY2024 Q310-QJun 30, 2024Aug 8, 2024147Open
FY2024 Q210-QMar 31, 2024May 9, 2024134Open
FY2024 Q110-QDec 31, 2023Feb 6, 2024138Open

Financial data

598 concepts · 12,095 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial592 concepts · 12,046 facts · Sep 2003 to Jul 2026

  • Stockholders equity including portion attributable to noncontrolling interest93 · Sep 2003 to Jun 2026
  • Net income loss88 · Sep 2003 to Jun 2026
  • Profit loss88 · Sep 2003 to Jun 2026
  • Adjustments to additional paid in capital sharebased compensation requisite service period recognition value82 · Sep 2004 to Jun 2026
  • Nonoperating income expense81 · Jun 2010 to Jun 2026
  • Operating expenses (US GAAP)81 · Jun 2010 to Jun 2026
  • Operating income loss81 · Jun 2010 to Jun 2026
  • Common stock par or stated value per share80 · Sep 2010 to Jun 2026
  • Increase decrease in accounts payable80 · Sep 2010 to Jun 2026
  • Increase decrease in accrued liabilities80 · Sep 2010 to Jun 2026
  • Share based compensation80 · Jun 2010 to Jun 2026
  • Accounts payable current79 · Sep 2010 to Jun 2026
  • Accrued liabilities current79 · Sep 2010 to Jun 2026
  • Accumulated depreciation depletion and amortization property plant and equipment79 · Sep 2010 to Jun 2026
  • Assets79 · Sep 2010 to Jun 2026
  • Assets current79 · Sep 2010 to Jun 2026
  • Common stock shares authorized79 · Sep 2010 to Jun 2026
  • Common stock shares issued79 · Sep 2010 to Jun 2026
  • Common stock shares outstanding79 · Sep 2010 to Jun 2026
  • Common stock value79 · Sep 2010 to Jun 2026
  • Employee related liabilities current79 · Sep 2010 to Jun 2026
  • General and administrative expense (US GAAP)79 · Jun 2010 to Dec 2025
  • Liabilities and stockholders equity79 · Sep 2010 to Jun 2026
  • Liabilities current79 · Sep 2010 to Jun 2026

Segment6 concepts · 49 facts · Sep 2023 to Jun 2026

  • Operating Segment10 · Sep 2023 to Jun 2026
  • Professional fees10 · Sep 2023 to Jun 2026
  • Research and development expense10 · Sep 2023 to Jun 2026
  • Salaries wages and officers compensation10 · Sep 2023 to Jun 2026
  • General and administrative expense (US GAAP)5 · Sep 2023 to Dec 2025
  • Selling general and administrative expense4 · Mar 2025 to Jun 2026

Segments

49 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments1 member · 49 facts

  • Operating49 · Sep 2023 to Jun 2026

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Earnings-release commentary103 claims from 8 reports · Sep 2024 to Jun 2026
  • Management discussion (MD&A) commentary140 claims from 9 reports · Sep 2024 to Jun 2026
  • Risk-factor changes20 claims from 1 reports · Sep 2025
  • Risk factors125 risks from 2 annual reports · 2024 to 2025

Earnings calls

2 calls · May 2026 to Aug 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q3Aug 4, 2026
  • FY2026 Q2May 7, 2026

Executive media

2 appearances

Podcasts, interviews and conference appearances by the company's executives, with their claims.

  • Other appearances2 · Aug 2020 to Jun 2023

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.

Arrowhead Pharmaceuticals Inc. (ARWR) data · FactIQ